H2020 and beyond: skip discrepancy between theory and practice of Personalized Medicine. A position paper by the Italian Society of Personalized Medicine.

H2020 and beyond: skip discrepancy between theory and practice of Personalized Medicine. A position paper by the Italian Society of Personalized Medicine.
Curr Pharm Biotechnol. 2016 May 19;
Authors: Borro M, Simmaco M, Aceti A, Barni S, De Luca A, Fineschi V, Frati P, Girardi P, Miozzo M, Nati G, Nicoletti F, Santini D, Marchetti P
Abstract
Many unsolved practical issues, from technical and scientific to ethical, legal and economic topics, are slowing down the translation of Personalized Medicine principles into medical practice. The Italian Society of Personalized Medicine exposes here its point of view, based on the real-world practice of precision medicine carried-out in Italian healthcare structures.
PMID: 27194357 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Biotechnology - May 18, 2016 Category: Biotechnology Authors: Borro M, Simmaco M, Aceti A, Barni S, De Luca A, Fineschi V, Frati P, Girardi P, Miozzo M, Nati G, Nicoletti F, Santini D, Marchetti P Tags: Curr Pharm Biotechnol Source Type: research